Clinical trial
Trial of rPA-102 Vaccine in Healthy Adult Volunteers
NCT00100724 · VaxGen, Industry · Completed
Key facts
| NCT number | NCT00100724 |
|---|---|
| Title | Trial of rPA-102 Vaccine in Healthy Adult Volunteers |
| Official title | A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers |
| Lead sponsor | VaxGen, Industry |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anthrax |
| Intervention type | Biological |
| Interventions | rPA102 |
| Enrollment | 480 |
| Start date | Apr 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Jan 6, 2005 |
| Last update posted | Jan 12, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: